Sarah Thompson spearheads research initiatives at Omni Care Oasis LLC, focusing on groundbreaking innovations like Fibrosyn TLHP and Synthetic Restorative Cartilage. With a PhD in Biomedical Engineering, Sarah combines her scientific expertise with a passion for improving patient health outcomes. She leads a dynamic team dedicated to pushing the boundaries of regenerative medicine. Her contributions are vital as OCO strives to set new benchmarks in healthcare by 2030, ensuring that science translates into tangible care for patients in need.